KALV- Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 15 buys and 5 sells. KALV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palleiko Benjamin L	462.6K	$12.49M	-
Other	Yea Christopher	223.5K	$6.03M	-
Other	Audhya Paul K.	142.5K	$3.85M	-
Other	Arif Bilal	100.0K	$2.70M	-
Other	Sweeny Nicole	51.4K	$1.39M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 14, 2024	Feener Edward P.72	Chief Scientific Officer	Sell	28,171	$15.01	$422,826.99	-28.2%	-13.3%	-33.8%
Feb 14, 2024	Yea Christopher53	Chief Development Officer	Sell	39,886	$15.01	$598,660.94	-37.6%	-13.3%	-33.8%
Feb 8, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	86,048	$14.62	$1,257,828.78	+0.6%	-19.1%	-38.3%
Feb 1, 2024	Crockett Thomas Andrew72	CEO	Sell	10,000	$16.22	$162,198.44	-4.1%	-22.6%	-43.4%
Jan 30, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	88,099	$14.47	$1,274,792.53	+1.9%	-25.7%	-40.8%
Jan 29, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	91,804	$14.05	$1,289,802.42	+0.7%	-23.2%	-38.1%
Jan 24, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	99,129	$12.53	$1,241,684.52	+0.7%	-7.8%	-28.0%
Jan 19, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	143,605	$12.55	$1,801,601.80	+1.1%	-7.3%	-33.1%
Jan 16, 2024	Venrock Healthcare Capital Partners Iii, L.P.54	10% Owner	Buy	26,246	$12.72	$333,779.23	+0.3%	-8.5%	-38.7%
Jan 11, 2024	Feener Edward P.72	Chief Scientific Officer	Sell	22,679	$13.03	$295,514.17	-36.3%	-9.1%	-40.2%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC